Biocon Biologics: FDA Approves YESAFILI As First Interchange

Biocon Biologics: FDA Approves YESAFILI As First Interchangeable Biological Product To Eylea

(RTTNews) - Biocon Biologics, a subsidiary of Biocon Ltd, announced the FDA has approved the company's first-to-file application for Yesafili, an ...

Related Keywords

United States , Biocon Biologics , Shreehas Tambe , Biocon Ltd , More Such Health News ,